FLT1 and Arthritis: Interestingly, the failure of anti-KDR Ab, but not of anti-Flt-1 Ab, to block arthritis and atherosclerosis [24, 25, 39], indicates that anti-inflammation, rather than antiangiogenesis, may be primarily responsible for the observed effects of anti-VEGF Ab.